⌘K

Consolidated Financial Position at March 31.2025

RNS Number : 4189I

Commercial Intnl Bank (Egypt) SAE

13 May 2025

Click on, or paste the following link into your web browser, to view the associated PDF document.

http://www.rns-pdf.londonstockexchange.com/rns/4189I_1-2025-5-13.pdf

Condensed Consolidated Interim Statement of Financial Position as at March 31, 2025

	Notes	Mar. 31, 2025	Dec. 31, 2024

Assets
Cash and balances at the central bank	9	68,810,514	136,531,020
Due from banks	10	314,305,928	270,829,834
Loans and advances to banks, net	12	16,109,873	9,555,410
Loans and advances to customers, net	13	364,274,475	343,542,674
Derivative financial instruments		930,893	819,711
Financial investments
- Financial Assets at Fair Value through OCI	14	261,161,290	234,512,167
- Financial Assets at Amortized cost	14	189,243,425	168,118,219
Investments in associates	15	35,384	98,193
Other assets	16	40,510,451	44,282,773
Deferred tax assets		2,804,720	2,685,331
Property and equipment	17	4,698,499	3,997,929
Total assets		1,262,885,452	1,214,973,261
Liabilities and equity
Liabilities
Due to banks	18	4,321,002	2,034,885
Due to customers	19	1,000,617,577	972,595,958
Non-current liabilities held for sale	30.2	1,397	1,397
Derivative financial instruments		78,314	100,571
Current income tax liabilities		5,565,862	18,327,968
Other liabilities	20	46,045,132	21,441,169
Issued debt instruments	21	5,044,951	5,067,781
Other loans		23,948,624	23,962,389
Other provisions	22	19,045,051	18,621,822
Total liabilities		1,104,667,910	1,062,153,940
Equity
Issued and paid capital		30,431,580	30,431,580
Reserves		88,394,260	63,544,579
Reserve for employee stock ownership plan (ESOP)		2,184,420	1,868,235
Retained earnings*		36,940,838	56,791,883
Total equity and net profit for the period / year		157,951,098	152,636,277
Non-Controlling Interest		266,444	183,044
Total NCI, equity and net profit for the period / year		158,217,542	152,819,321
Total liabilities and equity		1,262,885,452	1,214,973,261


The accompanying notes are an integral part of these financial statements.
(Review report attached)
*Including net profit for the period

Islam Zekry		Hisham Ezz Al-Arab
Group CFO & Executive Board Member		CEO & Executive Board Member

Condensed Consolidated Interim Income Statement for the period ended March 31, 2025

	Notes	Mar. 31, 2025	Mar. 31, 2024

Interest and similar income		52,535,156	36,652,802
Interest and similar expense		(27,139,272)	(17,852,691)
Net interest income		25,395,884	18,800,111

Fee and commission income		3,522,513	2,685,963
Fee and commission expense		(1,587,691)	(1,118,912)
Net fee and commission income		1,934,822	1,567,051

Dividend income		12,751	610
Net trading income	6	644,549	16,202,148
Profits (Losses) on financial investments	14.1	472,532	224,271
Administrative expenses		(3,932,425)	(2,928,640)
Other operating income (expenses)	7	(1,742,230)	(14,975,056)
Impairment release (charges) for credit losses		(84,032)	(1,421,114)
Bank's share in the profits / losses of associates		(297)	4,931
Profit before income tax		22,701,554	17,474,312

Income tax expense	27	(6,479,828)	(5,926,187)
Deferred tax assets (Liabilities)	27	411,443	376,765
Net profit for the period		16,633,169	11,924,890

Non-Controlling Interest		1,394	456
Bank's shareholders		16,631,775	11,924,434

Earnings per share	8
Basic		4.83	3.47
Diluted		4.79	3.45





Islam Zekry		Hisham Ezz Al-Arab
Group CFO & Executive Board Member		CEO & Executive Board Member

Condensed Consolidated Interim statement of Comprehensive Income for the period ended March 31, 2025
	Last 9 Months	Last 9 Months
	Mar. 31, 2025	Mar. 31, 2024

Net profit for the period	16,633,169	11,924,890

Net change on financial assets at fair value through comprehensive income after tax	2,491,322	1,915,786
Cumulative foreign currencies translation differences	(169,708)	831,452
Effect of ECL on fair value of debt instruments measured at fair value through comprehensive income	841,687	744,813
Total comprehensive income for the period	19,796,470	15,416,941


As follows:
Bank's shareholders	19,713,070	15,416,485
Non-Controlling Interest	83,400	456
Total comprehensive income for the period	19,796,470	15,416,941

Condensed Consolidated Interim Cash flows for the period ended March 31, 2025

	Notes	Mar. 31, 2025	Mar. 31, 2024

Cash flow from operating activities
Profit before income tax		22,701,554	17,474,312
Adjustments to reconcile profits to net cash provided by operating activities
Fixed assets depreciation	17	773,002	261,427
Impairment release/charge for credit losses (Loans and advances to customers and banks)		(1,080,606)	1,712,500
Other provisions release/charge	22	320,589	41,587
Impairment release/charge for credit losses (due from banks)		141,071	(646)
Impairment release/charge for credit losses (financial investments)		1,023,567	(290,740)
Impairment release/charge for other assets		-	(4,782)
Exchange revaluation differences for financial assets at fair value through OCI and AC		212,785	(17,328,576)
Revaluation differences impairment charge for Financial Assets at Fair value through OCI		(13,267)	1,130,412
Revaluation differences impairment charge for Financial Assets at Amortized cost		1,240	95,225
Revaluation differences impairment charge for due from banks		(18)	1,393
Net utilized / recovered of other provisions	22	(520)	(4,517)
Exchange revaluation differences of other provisions	22	103,160	3,574,589
Profits/losses from selling property and equipment	7	(6,006)	-
Profits/losses from selling financial investments at fair value through OCI	14.1	(195,124)	(224,271)
Profits/losses from selling investments in associates		(277,408)	-
Share based payments		316,185	300,000
Bank's share in the profits / losses of associates		297	(4,931)
Operating profits before changes in operating assets and liabilities		24,020,501	6,732,982

Net decrease / increase in assets and liabilities
Due from banks		123,055,498	41,887,372
Financial assets at fair value through P&L		-	(974,297)
Derivative financial instruments		(142,036)	157,890
Loans and advances to banks and customers		(26,205,658)	(37,541,091)
Other assets		6,009,359	(5,893,831)
Non-current assets held for sale		-	(244)
Due to banks	18	2,286,117	(6,928,939)
Due to customers	19	28,021,619	118,843,058
Current income tax obligations paid		(913,966)	(480,418)
Non-current liabilities held for sale		-	1,297
Other liabilities		5,721,712	1,820,664
Net cash generated from (used in) operating activities		161,853,146	117,624,443

Cash flow from investing activities
Proceeds from sale of investments in associates		226,698	4,782
Payments for purchases of property, equipment and branches construction		(3,597,387)	(437,370)
Proceeds from selling property and equipment		6,006	-
Proceeds from redemption of financial assets at amortized cost		2,579,713	285,507
Payments for purchases of financial assets at amortized cost		(23,883,457)	(53,615,996)
Payments for purchases of financial assets at fair value through OCI		(29,279,247)	(26,592,698)
Proceeds from selling financial assets at fair value through OCI		6,310,466	26,222,450
Net cash generated from (used in) investing activities		(47,637,208)	(54,133,325)

Condensed Consolidated Interim Cash flows for the period ended March 31, 2025 (Cont.)

		Mar. 31, 2025	Mar. 31, 2024

Cash flow from financing activities
Other loans		(13,765)	6,700,881
Dividends paid		(14,160,152)	(5,078,792)
Issued debt instruments		(22,830)	1,626,167
Net cash generated from (used in) financing activities		(14,196,747)	3,248,256

Net (decrease) increase in cash and cash equivalent during the period		100,019,191	66,739,374
Beginning balance of cash and cash equivalent		226,610,721	234,317,913
Cash and cash equivalent at the end of the period		326,629,912	301,057,287

Cash and cash equivalent comprise:
Cash and balances at the central bank	9	68,810,514	36,731,091
Due from banks		314,450,806	292,723,938
Treasury bills and other governmental notes	11	116,419,815	119,754,167
Obligatory reserve balance with central bank		(43,885,546)	(19,531,282)
Due from banks with maturity more than three months		(14,867,792)	(8,740,302)
Treasury bills and other governmental notes with maturity more than three months		(114,297,885)	(119,880,325)
Total cash and cash equivalent		326,629,912	301,057,287

Condensed Consolidated Interim statement of changes in shareholders' equity
Mar. 31, 2024	Issued and paid capital	Legal reserve	General reserve	General risk reserve	Reserve for transactions under common control	Capital reserve	Reserve for financial assets at fair value through OCI	Banking risks reserve	Retained earnings	Reserve for employee stock ownership plan	Cumulative foreign currencies translation differences	Total Shareholders' Equity	Non-Controlling Interest	Total

Beginning balance	30,195,010	4,770,354	39,840,707	1,550,906	(670,972)	21,155	(16,868,691)	15,230	29,993,331	1,486,010	148,353	90,481,393	160,073	90,641,466
Transferred to reserves	-	1,438,320	21,958,960	-	-	1,663	-	-	(23,398,943)	-	-	-	-	-
Net profit for the period	-	-	-	-	-	-	-	-	11,924,434	-	-	11,924,434	456	11,924,890
Dividends paid	-	-	-	-	-	-	-	-	(5,366,429)	-	-	(5,366,429)	-	(5,366,429)
Net change on financial assets at fair value through OCI after tax	-	-	-	-	-	-	1,915,786	-	-	-	-	1,915,786	-	1,915,786
Transferred (from) to banking risk reserve	-	-	-	-	-	-	-	21,718	(21,718)	-	-	-	-	-
Effect of ECL in fair value of debt instruments measured at fair value through OCI	-	-	-	-	-	-	744,813	-	-	-	-	744,813	-	744,813
Cost of employees stock ownership plan (ESOP)	-	-	-	-	-	-	-	-	-	300,000	-	300,000	-	300,000
Cumulative foreign currencies translation differences	-	-	-	-	-	-	-	-	-	-	831,452	831,452	(321)	831,131
Ending balance	30,195,010	6,208,674	61,799,667	1,550,906	(670,972)	22,818	(14,208,092)	36,948	13,130,675	1,786,010	979,805	100,831,449	160,208	100,991,657

Mar. 31, 2025	Issued and paid capital	Legal reserve	General reserve	General risk reserve	Reserve for transactions under common control	Capital reserve	Reserve for financial assets at fair value through OCI	Banking risks reserve	Retained earnings	Reserve for employee stock ownership plan	Cumulative foreign currencies translation differences	Total Shareholders' Equity	Non-Controlling Interest	Total

Beginning balance	30,431,580	6,208,674	62,422,792	1,550,906	(670,972)	22,818	(7,145,283)	17,924	56,791,883	1,868,235	1,137,720	152,636,277	183,044	152,819,321
Transferred to reserves	-	2,771,284	18,971,298	-	-	2,246	-	-	(21,744,828)	-	-	-	-	-
Dividends paid	-	-	-	-	-	-	-	-	(14,714,434)	-	-	(14,714,434)	-	(14,714,434)
Net profit for the period	-	-	-	-	-	-	-	-	16,631,775	-	-	16,631,775	1,394	16,633,169
Transferred to general risk reserve	-	-	-	26,186	-	-	-	-	(26,186)	-	-	-	-	-
Net change on financial assets at fair value through OCI after tax	-	-	-	-	-	-	2,409,316	-	-	-	-	2,409,316	82,006	2,491,322
Transferred (from) to banking risk reserve	-	-	-	-	-	-	-	(2,628)	2,628	-	-	-	-	-
Effect of ECL in fair value of debt instruments measured at fair value through OCI	-	-	-	-	-	-	841,687	-	-	-	-	841,687	-	841,687
Cost of employees stock ownership plan (ESOP)	-	-	-	-	-	-	-	-	-	316,185	-	316,185	-	316,185
Cumulative foreign currencies translation differences	-	-	-	-	-	-	-	-	-	-	(169,708)	(169,708)	-	(169,708)
Ending balance	30,431,580	8,979,958	81,394,090	1,577,092	(670,972)	25,064	(3,894,280)	15,296	36,940,838	2,184,420	968,012	157,951,098	266,444	158,217,542

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

QRFDZGMKDFVGKZG

Consolidated Financial Position at March 31.2025 - Commercial International Bank (egypt) S.A.E. (GDR) | RNS | Ticker